Budget impact analysis of the use of paricalcitol for the treatment of secondary hyperparathyroidism in chronic kidney disease. FE [Internet]. 2014 Sep. 30 [cited 2026 Feb. 15];15(3). Available from: https://journals.seedstm.com/index.php/FE/article/view/938